Evidence map›Paper›PMID 25071732›Full record

ArticleFrontiers in microbiology2014

Human decidual macrophages and NK cells differentially express Toll-like receptors and display distinct cytokine profiles upon TLR stimulation.

Marion Duriez, Héloïse Quillay, Yoann Madec, Hicham El Costa, Claude Cannou, Romain Marlin, Claire de Truchis, Mona Rahmati, Françoise Barré-Sinoussi, Marie-Thérèse Nugeyre and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Modulation of NK Cell Properties by ESKAPE Group Bacteria.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Innate immune defenses at the maternal-fetal interface.Current opinion in immunology · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Verbascoside-RichMolecules (Basel, Switzerland) · 2020
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Importance of heterogeneity inJournal of oral microbiology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Marion DuriezUnité de Régulation des Infections Rétrovirales, Institut Pasteur, Département de Virologie Paris, France ; Centre d'Immunologie et des Maladies Infectieuses, INSERM U1135, Sorbonne Universités, UPMC Univ Paris 06 Paris, France.
Héloïse QuillayUnité de Régulation des Infections Rétrovirales, Institut Pasteur, Département de Virologie Paris, France ; Cellule Pasteur, Université Paris Diderot, Sorbonne Paris Cité Paris, France.
Yoann MadecUnité d'Epidémiologie des Maladies Emergentes, Institut Pasteur Paris, France.
Hicham El CostaUnité de Régulation des Infections Rétrovirales, Institut Pasteur, Département de Virologie Paris, France.
Claude CannouUnité de Régulation des Infections Rétrovirales, Institut Pasteur, Département de Virologie Paris, France.
Romain MarlinUMR-CNRS-5164-CIRID, Université Bordeaux 2 Bordeaux, France.
Claire de TruchisGynecology-Obstetrics Service, A. Béclère Hospital, AP-HP Clamart, France.
Mona RahmatiGynecology-Obstetrics Service, Pitié Salpêtrière Hospital AP-HP Paris, France.
Françoise Barré-SinoussiUnité de Régulation des Infections Rétrovirales, Institut Pasteur, Département de Virologie Paris, France.
Marie-Thérèse NugeyreUnité de Régulation des Infections Rétrovirales, Institut Pasteur, Département de Virologie Paris, France.
Elisabeth MenuUnité de Régulation des Infections Rétrovirales, Institut Pasteur, Département de Virologie Paris, France.
Assistance Publique – Hôpitaux de Paris · FRInstitut Pasteur · FRSorbonne Paris Cité · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternofetal pathogen transmission is partially controlled at the level of the maternal uterine mucosa at the fetal implantation site (the decidua basalis), where maternal and fetal cells are in close contact. Toll-like receptors (TLRs) may play an important role in initiating rapid immune responses against pathogens in the decidua basalis, however the tolerant microenvironment should be preserved in order to allow fetal development. Here we investigated the expression and functionality of TLRs expressed by decidual macrophages (dMs) and NK cells (dNKs), the major decidual immune cell populations. We report for the first time that both human dMs and dNK cells express mRNAs encoding TLRs 1-9, albeit with a higher expression level in dMs. TLR2, TLR3, and TLR4 protein expression checked by flow cytometry was positive for both dMs and dNK cells. In vitro treatment of primary dMs and dNK cells with specific TLR2, TLR3, TLR4, TLR7/8, and TLR9 agonists enhanced their secretion of pro- and anti-inflammatory cytokines, as well as cytokines and chemokines involved in immune cell crosstalk. Only dNK cells released IFN-γ, whereas only dMs released IL-1β, IL-10, and IL-12. TLR9 activation of dMs resulted in a distinct pattern of cytokine expression compared to the other TLRs. The cytokine profiles expressed by dMs and dNK cells upon TLR activation are compatible with maintenance of the fetotolerant immune environment during initiation of immune responses to pathogens at the maternofetal interface.

Indexed as

cytokinesdeciduainnate mucosal immunitymacrophagesmaternofetal interfaceNK cellsTLR

Identifiers

PMID25071732
PMCPMC4076550
OpenAlexW2034841504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.